AI Summary
Summary: The article discusses a study on testicular cancer survivors who received cisplatin-based chemotherapy, showing that 78% experienced significant hearing loss after an average of 14 years. This finding highlights the potential long-term effects of chemotherapy on survivors' quality of life.
A new study tracked a cohort of testicular cancer survivors who received cisplatin-based chemotherapy for an average of 14 years, revealing that 78% experience significant difficulties in everyday listening situations, negatively impacting their quality of life.